bpc-157 peptide fda bpc 157 classification 5 Peptides Under FDA Scrutiny: What You Need to Know Big FDA review coming this
Description
They may be able to recommend ways to decrease this side effect
BMJ Open Diabetes Res Care

The comparison between AOD9604 and CJC-1295 reveals distinctions similar to the tesamorelin comparison AOD9604 provides targeted fat loss without a systemic GH rise, while CJC-1295 increases GH and IGF-1 with broader physiological effects

This is where BPC 157 fits into bodybuilding discussions

Although there seems to be some promise for the future, at this point, I think theres too much uncertainty and unnecessary risk involved